Ally Bridge Group (Ny) LLC Black Diamond Therapeutics, Inc. Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.65 - $7.39 $3.88 Million - $6.17 Million
835,000 New
835,000 $3.89 Million
Q3 2023

Nov 14, 2023
SELL
$2.87 - $4.99 $475,871 - $827,386
-165,809 Reduced 20.73%
634,191 $1.82 Million
Q2 2023

Aug 14, 2023
BUY
$1.43 - $6.18 $1.14 Million - $4.94 Million
800,000 New
800,000 $4.04 Million

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $95.9M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email